Another meta-analysis on pancreatic cancer specifically also showed that GLP-1RAs were not associated with increased risk for pancreatic cancer as compared with other treatments (93)
Discussion The clinical management of patients with type 2 diabetes has to balance the potential benefits of controlling hyperglycemia on microvascular and macrovascular complications, [11] with possible side effects of treatment and possible harm from over intensive control of glycemia
Although these compounds belong to the same broader pharmacological family, they differ substantially in receptor selectivity and research applications
Ive provided a list below of my top 3 drug interactions with GLP-1 agonists
Is the medication part of the price, or a separate pharmacy bill
100 nmol/L), (3) HG plus GLP-1(3236) and shRNA against GLP-1R (1:500), (4) HG plus GLP-1(3236) and shRNA sequence as negative control (1:500), and (5) mannitol group (without HG and peptides)